Insider Selling: PACS Group (NYSE:PACS) Director Sells $6,444,248.79 in Stock

Posted by Francis Steltz on Jul 9th, 2026

PACS Group, Inc. (NYSE:PACS – Get Free Report) Director Mark Hancock sold 142,163 shares of the business’s stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $45.33, for a total value of $6,444,248.79. Following the completion of the sale, the director owned 53,945,816 shares of the company’s stock, valued at $2,445,363,839.28. This trade represents a 0.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Hancock also recently made the following trade(s):

On Thursday, July 2nd, Mark Hancock sold 12,825 shares of PACS Group stock. The shares were sold at an average price of $45.01, for a total value of $577,253.25.
On Wednesday, July 1st, Mark Hancock sold 6,080 shares of PACS Group stock. The shares were sold at an average price of $45.02, for a total transaction of $273,721.60.
On Friday, June 26th, Mark Hancock sold 61,931 shares of PACS Group stock. The stock was sold at an average price of $40.50, for a total transaction of $2,508,205.50.
On Thursday, June 25th, Mark Hancock sold 138,069 shares of PACS Group stock. The stock was sold at an average price of $40.33, for a total transaction of $5,568,322.77.
On Wednesday, June 17th, Mark Hancock sold 63,680 shares of PACS Group stock. The shares were sold at an average price of $35.31, for a total transaction of $2,248,540.80.
On Tuesday, June 16th, Mark Hancock sold 83,066 shares of PACS Group stock. The shares were sold at an average price of $35.90, for a total transaction of $2,982,069.40.
On Monday, June 15th, Mark Hancock sold 153,254 shares of PACS Group stock. The shares were sold at an average price of $36.34, for a total transaction of $5,569,250.36.

PACS Group Stock Up 0.7%

PACS stock opened at $43.93 on Thursday. The stock has a market capitalization of $6.95 billion, a P/E ratio of 28.16, a P/E/G ratio of 1.30 and a beta of -0.08. The firm has a 50-day simple moving average of $37.72 and a 200-day simple moving average of $36.84. The company has a quick ratio of 0.99, a current ratio of 0.99 and a debt-to-equity ratio of 0.27. PACS Group, Inc. has a 52 week low of $7.50 and a 52 week high of $45.89.

PACS Group (NYSE:PACS – Get Free Report) last issued its quarterly earnings results on Monday, May 11th. The company reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.42 by $0.08. PACS Group had a net margin of 4.49% and a return on equity of 26.47%. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.36 billion. Equities analysts forecast that PACS Group, Inc. will post 2.23 earnings per share for the current fiscal year.

Institutional Investors Weigh In On PACS Group

Large investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in PACS Group by 14.4% during the fourth quarter. Vanguard Group Inc. now owns 4,506,227 shares of the company’s stock worth $172,994,000 after buying an additional 566,502 shares during the last quarter. Alyeska Investment Group L.P. raised its holdings in shares of PACS Group by 159.5% during the 4th quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company’s stock worth $86,378,000 after acquiring an additional 1,382,984 shares during the period. Crewe Advisors LLC boosted its position in shares of PACS Group by 93.1% during the 4th quarter. Crewe Advisors LLC now owns 2,147,815 shares of the company’s stock valued at $82,455,000 after acquiring an additional 1,035,747 shares during the last quarter. Balyasny Asset Management L.P. grew its holdings in shares of PACS Group by 67.3% in the third quarter. Balyasny Asset Management L.P. now owns 1,356,240 shares of the company’s stock valued at $18,621,000 after purchasing an additional 545,348 shares during the period. Finally, Ameriprise Financial Inc. increased its position in PACS Group by 19.6% during the third quarter. Ameriprise Financial Inc. now owns 1,350,551 shares of the company’s stock worth $18,543,000 after purchasing an additional 220,939 shares during the last quarter.

Analyst Upgrades and Downgrades

PACS has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of PACS Group in a research note on Wednesday, June 24th. UBS Group increased their price objective on PACS Group from $50.00 to $57.00 and gave the company a “buy” rating in a research note on Wednesday. Zacks Research lowered PACS Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 14th. Truist Financial lifted their target price on shares of PACS Group from $50.00 to $52.00 and gave the stock a “buy” rating in a research note on Monday, May 18th. Finally, Oppenheimer upped their target price on shares of PACS Group from $42.00 to $48.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Five equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $50.60.

View Our Latest Analysis on PACS

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.